Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors. J of Skin. 2026;10(2):s728. doi:10.25251/wx06pe13